Ingevity (NGVT) EPS (Weighted Average and Diluted) (2016 - 2025)
Ingevity (NGVT) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with -$2.25 as the latest value for Q4 2025.
- On a quarterly basis, EPS (Weighted Average and Diluted) fell 125.08% to -$2.25 in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.61, a 38.44% decrease, with the full-year FY2025 number at -$4.61, down 38.02% from a year prior.
- EPS (Weighted Average and Diluted) was -$2.25 for Q4 2025 at Ingevity, down from $1.1 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $8.97 in Q4 2024 to a low of -$7.81 in Q2 2024.
- A 5-year average of $0.02 and a median of $0.73 in 2021 define the central range for EPS (Weighted Average and Diluted).
- Peak YoY movement for EPS (Weighted Average and Diluted): soared 1890.91% in 2022, then crashed 905.15% in 2024.
- Ingevity's EPS (Weighted Average and Diluted) stood at $0.76 in 2021, then plummeted by 42.11% to $0.44 in 2022, then crashed by 818.18% to -$3.16 in 2023, then skyrocketed by 383.86% to $8.97 in 2024, then tumbled by 125.08% to -$2.25 in 2025.
- Per Business Quant, the three most recent readings for NGVT's EPS (Weighted Average and Diluted) are -$2.25 (Q4 2025), $1.1 (Q3 2025), and -$4.02 (Q2 2025).